Hyperglycemia-Induced Immune System Disorders in Diabetes Mellitus and the Concept of Hyperglycemic Memory of Innate Immune Cells: A Perspective.

MLA

Lisco, Giuseppe, et al. “Hyperglycemia-Induced Immune System Disorders in Diabetes Mellitus and the Concept of Hyperglycemic Memory of Innate Immune Cells: A Perspective.” Endocrine, Metabolic & Immune Disorders Drug Targets, vol. 22, no. 4, 2022, pp. 367–70. EBSCOhost, https://doi.org/10.2174/1871530321666210924124336.

APA

Lisco, G., Giagulli, V. A., De Pergola, G., Guastamacchia, E., Jirillo, E., & Triggiani, V. (2022). Hyperglycemia-Induced Immune System Disorders in Diabetes Mellitus and the Concept of Hyperglycemic Memory of Innate Immune Cells: A Perspective. Endocrine, Metabolic & Immune Disorders Drug Targets, 22(4), 367–370. https://doi.org/10.2174/1871530321666210924124336

Chicago

Lisco, Giuseppe, Vito Angelo Giagulli, Giovanni De Pergola, Edoardo Guastamacchia, Emilio Jirillo, and Vincenzo Triggiani. 2022. “Hyperglycemia-Induced Immune System Disorders in Diabetes Mellitus and the Concept of Hyperglycemic Memory of Innate Immune Cells: A Perspective.” Endocrine, Metabolic & Immune Disorders Drug Targets 22 (4): 367–70. doi:10.2174/1871530321666210924124336.